Enliven Therapeutics (ELVN) Q3 2020 Earnings

5NovExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
-4.31
-2.87
-1.44
0

Details

Expected EPS
-0.8
Actual EPS
-0.72
Surprise EPS
0.08
Surprise Percent
+10%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.72 per share for Q3 2020.

0 Comments

Share your thoughts